Key FDA Decisions and Trial Results Expected in October

Key FDA Decisions and Trial Results Expected in October

Submitted by admin on September 8, 2016 - 9:50am
Source: 
24/7 Wall St
News Tags: 
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Headline: 
Key FDA Decisions and Trial Results Expected in October